Del Río Hortega's insights into oligodendrocytes: recent advances in subtype characterization and functional roles in axonal support and disease.

Eneritz López-Muguruza, Carla Peiró-Moreno, Fernando Pérez-Cerdá, Carlos Matute, Asier Ruiz
Author Information
  1. Eneritz López-Muguruza: Department of Neurosciences, University of the Basque Country UPV/EHU, Leioa, Spain.
  2. Carla Peiró-Moreno: Department of Neurosciences, University of the Basque Country UPV/EHU, Leioa, Spain.
  3. Fernando Pérez-Cerdá: Department of Neurosciences, University of the Basque Country UPV/EHU, Leioa, Spain.
  4. Carlos Matute: Department of Neurosciences, University of the Basque Country UPV/EHU, Leioa, Spain.
  5. Asier Ruiz: Department of Neurosciences, University of the Basque Country UPV/EHU, Leioa, Spain.

Abstract

Pío Del Río Hortega (1882-1945) was a giant of modern neuroscience and perhaps the most impactful member of Cajal's School. His contributions to clarifying the structure of the nervous system were key to understanding the brain beyond neurons. He uncovered microglia and oligodendrocytes, the latter until then named mesoglia. Most importantly, the characterization of oligodendroglia subtypes he made has stood the omics revolution that added molecular details relevant to comprehend their biological properties. Astounding as it may seem on today's eyes, he postulated a century ago that oligodendrocytes provide trophic support to axons, an idea that is now beyond doubt and under scrutiny as dysfunction at the axon-myelin unit is key to neurodegeneration. Here, we revised recent key advancements in oligodendrocyte biology that shed light on Hortega's ideas a century ago.

Keywords

References

  1. Nat Rev Drug Discov. 2020 Sep;19(9):609-633 [PMID: 32709961]
  2. Glia. 2019 Nov;67(11):2050-2062 [PMID: 31233642]
  3. Sci Rep. 2015 Jan 15;5:7805 [PMID: 25588812]
  4. Neuron. 2019 Feb 20;101(4):615-624.e5 [PMID: 30686733]
  5. Cell Rep. 2022 Oct 18;41(3):111480 [PMID: 36261002]
  6. Front Cell Neurosci. 2018 Nov 16;12:399 [PMID: 30524235]
  7. Neurochem Int. 2011 Feb;58(3):321-9 [PMID: 21184792]
  8. Front Cell Neurosci. 2022 Dec 20;16:1083159 [PMID: 36605616]
  9. Neurobiol Dis. 2004 Nov;17(2):155-62 [PMID: 15474353]
  10. Int J Mol Sci. 2019 Aug 30;20(17): [PMID: 31480294]
  11. J Anat. 2021 Dec;239(6):1241-1255 [PMID: 34713444]
  12. Front Aging Neurosci. 2015 Apr 21;7:52 [PMID: 25954194]
  13. Histochem Cell Biol. 2024 Feb;161(2):99-132 [PMID: 38244103]
  14. Biochimie. 2014 Mar;98:127-34 [PMID: 24262602]
  15. Neuroscientist. 2019 Aug;25(4):334-343 [PMID: 30122106]
  16. Front Psychiatry. 2020 Feb 28;11:122 [PMID: 32180741]
  17. Continuum (Minneap Minn). 2019 Jun;25(3):636-654 [PMID: 31162309]
  18. J Cell Biol. 1962 Feb;12:448-53 [PMID: 13874658]
  19. Neural Regen Res. 2025 May 1;20(5):1336-1349 [PMID: 38934385]
  20. Expert Opin Drug Deliv. 2011 May;8(5):623-32 [PMID: 21417782]
  21. J Neurosci. 2014 Sep 3;34(36):11929-47 [PMID: 25186741]
  22. Science. 2015 Mar 6;347(6226):1138-42 [PMID: 25700174]
  23. Glia. 2022 Nov;70(11):2045-2061 [PMID: 35762739]
  24. Curr Opin Neurobiol. 2023 Dec;83:102782 [PMID: 37703600]
  25. J Neurosci. 2015 Jan 7;35(1):4-20 [PMID: 25568099]
  26. Biomolecules. 2020 Jul 17;10(7): [PMID: 32708919]
  27. J Neurosci. 2020 Jan 8;40(2):256-266 [PMID: 31744863]
  28. Neurochem Int. 1991;18(1):85-8 [PMID: 20504680]
  29. Clin Neuropathol. 2012 Nov-Dec;31(6):437-9 [PMID: 23083462]
  30. Physiol Rev. 2001 Apr;81(2):871-927 [PMID: 11274346]
  31. J Cereb Blood Flow Metab. 2007 Nov;27(11):1766-91 [PMID: 17579656]
  32. Brain. 2008 Dec;131(Pt 12):3286-98 [PMID: 18927145]
  33. Nat Med. 2018 Dec;24(12):1837-1844 [PMID: 30420755]
  34. Nat Metab. 2023 Mar;5(3):445-465 [PMID: 36959514]
  35. Front Immunol. 2021 Aug 26;12:711362 [PMID: 34512632]
  36. Int J Mol Sci. 2022 Feb 25;23(5): [PMID: 35269720]
  37. Neurobiol Aging. 2011 Aug;32(8):1341-71 [PMID: 19775776]
  38. Curr Infect Dis Rep. 2017 Feb;19(2):7 [PMID: 28233190]
  39. Dialogues Clin Neurosci. 2018 Dec;20(4):283-292 [PMID: 30936768]
  40. Nature. 2019 Jun;570(7761):332-337 [PMID: 31042697]
  41. Acta Neuropathol. 1997 Apr;93(4):334-40 [PMID: 9113198]
  42. Behav Brain Res. 2008 Sep 1;192(1):106-13 [PMID: 18359102]
  43. Trends Immunol. 2024 Oct;45(10):750-759 [PMID: 39322475]
  44. Brain. 2007 May;130(Pt 5):1254-62 [PMID: 17293360]
  45. Semin Cell Dev Biol. 2021 Aug;116:45-52 [PMID: 33162336]
  46. Science. 2016 Jan 22;351(6271):379-84 [PMID: 26798014]
  47. Nat Genet. 2007 Aug;39(8):969-76 [PMID: 17643102]
  48. J Neurol Sci. 2003 Feb 15;206(2):187-91 [PMID: 12559509]
  49. J Neurosci. 2017 Oct 18;37(42):10185-10199 [PMID: 28931570]
  50. Acta Neuropathol. 2021 Jul;142(1):87-115 [PMID: 33978813]
  51. Front Neurosci. 2020 Jan 31;13:1410 [PMID: 32076395]
  52. J Neuroinflammation. 2015 Feb 22;12:34 [PMID: 25889069]
  53. J Neurosci. 2008 Jan 2;28(1):264-78 [PMID: 18171944]
  54. Biochimie. 2014 Mar;98:111-8 [PMID: 24120688]
  55. Fluids Barriers CNS. 2023 Apr 3;20(1):24 [PMID: 37013659]
  56. Am J Pathol. 2007 Oct;171(4):1291-303 [PMID: 17823288]
  57. Cell Rep. 2021 Jan 12;34(2):108610 [PMID: 33440165]
  58. J Clin Invest. 2017 Sep 1;127(9):3271-3280 [PMID: 28862639]
  59. Adv Neurobiol. 2016;13:275-294 [PMID: 27885633]
  60. Brain. 2008 Jul;131(Pt 7):1722-35 [PMID: 18515320]
  61. Food Funct. 2023 Jul 31;14(15):7247-7269 [PMID: 37466915]
  62. J Neurol. 2000 Jul;247(7):535-43 [PMID: 10993496]
  63. Int J Mol Sci. 2023 Jun 27;24(13): [PMID: 37445890]
  64. J Inherit Metab Dis. 2010 Oct;33(5):469-77 [PMID: 20195903]
  65. Physiol Rev. 2019 Jul 1;99(3):1381-1431 [PMID: 31066630]
  66. Purinergic Signal. 2012 Sep;8(3):343-57 [PMID: 22528680]
  67. Sci Rep. 2016 Sep 14;6:33249 [PMID: 27624721]
  68. Curr Neuropharmacol. 2022 Nov 15;20(12):2303-2319 [PMID: 36043794]
  69. J Biol Chem. 2023 Feb;299(2):102838 [PMID: 36581208]
  70. Curr Med Chem. 2016;23(8):816-31 [PMID: 26795198]
  71. Neuron. 2022 Nov 2;110(21):3458-3483 [PMID: 36327895]
  72. Nature. 2012 Apr 29;485(7399):517-21 [PMID: 22622581]
  73. PLoS One. 2014 Jul 31;9(7):e103174 [PMID: 25078775]
  74. Life (Basel). 2021 Mar 13;11(3): [PMID: 33805670]
  75. Nat Rev Dis Primers. 2022 Aug 25;8(1):56 [PMID: 36008429]
  76. Acta Neuropathol Commun. 2014 Sep 11;2:136 [PMID: 25208467]
  77. Int J Mol Sci. 2023 Aug 29;24(17): [PMID: 37686202]
  78. Int J Mol Sci. 2023 Aug 18;24(16): [PMID: 37629092]
  79. Front Cell Neurosci. 2019 May 24;13:187 [PMID: 31178695]
  80. Cells. 2021 Mar 05;10(3): [PMID: 33807572]
  81. J Neurosci. 2012 Jan 4;32(1):356-71 [PMID: 22219296]
  82. Trends Neurosci. 2013 Oct;36(10):587-97 [PMID: 23968694]
  83. PLoS One. 2017 Mar 14;12(3):e0173982 [PMID: 28291839]
  84. Curr Biol. 2015 Sep 21;25(18):2411-6 [PMID: 26320951]
  85. Clin Neuropathol. 2012 Nov-Dec;31(6):435-6 [PMID: 22943958]
  86. Nature. 2023 Jun;618(7964):349-357 [PMID: 37258678]
  87. Nat Neurosci. 2021 Mar;24(3):312-325 [PMID: 33589835]
  88. Nat Commun. 2023 May 24;14(1):2996 [PMID: 37225684]
  89. Annu Rev Neurosci. 2008;31:247-69 [PMID: 18558855]
  90. Nature. 2010 Nov 11;468(7321):244-52 [PMID: 21068833]
  91. Cold Spring Harb Perspect Med. 2018 Mar 1;8(3): [PMID: 29358320]
  92. JAMA Neurol. 2017 Jan 01;74(1):41-49 [PMID: 27842175]
  93. Anat Rec (Hoboken). 2020 May;303(5):1232-1241 [PMID: 31525279]
  94. J Neurosci. 2010 May 5;30(18):6236-46 [PMID: 20445049]
  95. Exp Neurol. 2014 Dec;262 Pt B:111-20 [PMID: 24859452]
  96. Front Nutr. 2021 Nov 12;8:775382 [PMID: 34869541]
  97. Front Neuroanat. 2015 Jul 07;9:92 [PMID: 26217196]
  98. Nature. 2012 Jul 26;487(7408):443-8 [PMID: 22801498]
  99. Annu Rev Neurosci. 2020 Jul 8;43:163-186 [PMID: 32075518]
  100. Nat Neurosci. 2013 May;16(5):571-9 [PMID: 23542689]
  101. Exp Neurol. 2018 Nov;309:23-31 [PMID: 30044944]
  102. Physiol Rev. 2019 Jan 1;99(1):949-1045 [PMID: 30565508]
  103. Mol Neurodegener. 2023 Jul 20;18(1):49 [PMID: 37475056]
  104. Mult Scler Int. 2015;2015:681289 [PMID: 26839705]
  105. Semin Cell Dev Biol. 2021 Apr;112:123-136 [PMID: 32773177]
  106. Mol Neurobiol. 2021 Jun;58(6):3000-3014 [PMID: 33604780]
  107. Front Neurol. 2019 Jun 12;10:585 [PMID: 31244753]
  108. Science. 2016 Jun 10;352(6291):1326-1329 [PMID: 27284195]
  109. Metabolism. 2016 Sep;65(9):1376-90 [PMID: 27506744]
  110. J Neurosci. 2016 Apr 27;36(17):4698-707 [PMID: 27122029]
  111. Acta Neuropathol Commun. 2018 Mar 2;6(1):22 [PMID: 29499767]
  112. Int J Geriatr Psychiatry. 2009 Feb;24(2):109-17 [PMID: 18637641]
  113. Front Cell Neurosci. 2022 Apr 28;16:892968 [PMID: 35573837]
  114. ASN Neuro. 2020 Jan-Dec;12:1759091420953259 [PMID: 33070631]
  115. Mult Scler. 2019 Jan;25(1):7-14 [PMID: 30270725]
  116. J Neurochem. 2025 Jan;169(1):e16219 [PMID: 39253904]
  117. Cell Rep. 2016 Apr 26;15(4):761-773 [PMID: 27149850]
  118. Int J Mol Sci. 2020 Nov 20;21(22): [PMID: 33233502]
  119. Curr Opin Neurobiol. 2017 Dec;47:168-175 [PMID: 29126015]
  120. Brain. 2013 Feb;136(Pt 2):471-82 [PMID: 23378219]
  121. Elife. 2019 Oct 28;8: [PMID: 31657718]
  122. Drugs. 2013 Dec;73(18):2017-29 [PMID: 24242317]
  123. Biochim Biophys Acta. 1981 Dec 23;666(3):411-7 [PMID: 7326251]
  124. Int J Mol Sci. 2021 Aug 23;22(16): [PMID: 34445796]
  125. J Neuroinflammation. 2021 Oct 28;18(1):248 [PMID: 34711251]
  126. Nat Neurosci. 2024 Oct;27(10):1934-1944 [PMID: 39251890]

Word Cloud

Created with Highcharts 10.0.0keyDelRíobeyondoligodendrocytescharacterizationcenturyagosupportrecentoligodendrocyteHortega'sdiseasePíoHortega1882-1945giantmodernneuroscienceperhapsimpactfulmemberCajal'sSchoolcontributionsclarifyingstructurenervoussystemunderstandingbrainneuronsuncoveredmicroglialatternamedmesogliaimportantlyoligodendrogliasubtypesmadestoodomicsrevolutionaddedmoleculardetailsrelevantcomprehendbiologicalpropertiesAstoundingmayseemtoday'seyespostulatedprovidetrophicaxonsideanowdoubtscrutinydysfunctionaxon-myelinunitneurodegenerationrevisedadvancementsbiologyshedlightideasinsightsoligodendrocytes:advancessubtypefunctionalrolesaxonalaxonmetabolismmyelin

Similar Articles

Cited By